For participants who had AUD, obesity and type 2 diabetes, the use of GLP-1 medications was linked to "substantially ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.